期刊文献+

胱抑素C水平与非急性卒中患者缺血性脑白质病变严重程度的相关性研究

Correlation of Cystatin C levels with the Severity of Ischemic White Matter Lesions in Patients with Non-acute Stroke
下载PDF
导出
摘要 目的:分析非急性卒中患者胱抑素C水平与缺血性脑白质病变严重程度的相关性。方法:纳入2022年1月至2022年6月在石河子市人民医院住院的非急性卒中患者116例,分析患者临床资料,记录患者相关数据,采用有序Logistic回归分析检测胱抑素C水平与缺血性脑白质病变严重程度的相关性。结果:不同程度的缺血性脑白质病变患者胱抑素C水平存在明显差异(P<0.05),胱抑素C是缺血性脑白质病变严重程度的独立危险因素(OR值55.257);高血压史、受教育程度低、同型半胱氨酸、红细胞分布宽度亦为缺血性脑白质病变独立危险因素。结论:胱抑素C水平与缺血性脑白质病变严重程度独立相关。 Objective:To analyze the correlation between serum cystatin C concentration and the severity of white matter lesions in non-acute stroke patients.Methods:A total of 116 patients hospitalized in Shihezi People's Hospital for non-acute stroke from January 2022 to June 2022 were included in the current study.Clinical data were collected and analyzed;ordinal Logistic regression analysis was employed to examine the correlation between patients′serum cystatin C concentration and the severity of their respective white matter lesions.Results:Difference of statistical significance could be found in the serum cystatin C concentration among patients of ischemic white matter lesions of different severity(P<0.05),which proves to be an independent risk factor for the severity of ischemic white matter lesions(OR=55.257).Hypertension,the lower educational background,serum homocysteine concentration,and red blood cell distribution width are also independent risk factors predictive of the severity thereof.Conclusion:Serum cystatin C is independently correlational to the severity of ischemic white matter lesions.
作者 徐瑞辰 陈飞 孟宪鑫 庞华军 鄢潞潞 XYU Rui-chen;CHEN Fei;MENG Xian-xin;PANG Hua-jun;YAN Lu-lu(Department of Medical Imaging,Shihezi People's Hospital,Xinjiang Shihezi,832000)
出处 《农垦医学》 2024年第2期121-124,135,共5页 Journal of Nongken Medicine
基金 新疆生产建设兵团第八师石河子市科技计划项目(2022NY05)。
关键词 脑白质病变 胱抑素C 危险因素 MRI Fazekas分级 White Matter Lesions Cystatin C Risk Factors MRI Fazekas Scale
  • 相关文献

参考文献19

二级参考文献118

  • 1冯建芳,汪淑荣,李平,赵一鸣,孙诠,师树古,陈明哲.急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化[J].基础医学与临床,1995,15(4):45-47. 被引量:20
  • 2张振馨.认知功能障碍研究进展[J].中华内科杂志,2005,44(8):633-634. 被引量:54
  • 3Lindhoh JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg,2001,88 : 1472 - 1475.
  • 4Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest,1999,104 : 1191 - 1197.
  • 5Barka T,van der Noen H. Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart: use of digoxigeninlabeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations. J Histochem Cytochem,1993,41 : 1863 - 1867.
  • 6Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA,1995,274 : 1049 - 1057.
  • 7Bostom AG, Bausserman L, Jacques PF, et al. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol, 1999,19 : 2241 -2244.
  • 8Takeyabu K,Betsuyaku T,Nishimura M ,et al. Cysteine proteinases and Cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J, 1998,12 : 1033 -1039.
  • 9Jonsdottir S, Palsdottir A. Molecular diagnosis of hereditary Cystatin C amyloid angiopathy. Biochem Med Metab Biol,1993,49 : 117 - 123.
  • 10Laterza OF,Price CP,Scott MG.Cystatin C:an improved estimator of glomerular filtration rate?Clin Chem,2002,48(5):699-707.

共引文献716

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部